Man Group PLC Anika Therapeutics, Inc. Transaction History

Man Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$18.47 - $23.3 $57,257 - $72,230	3,100 Added 11.65%	29,700 $673,000
Q3 2023 Nov 14, 2023	BUY	$16.98 - $26.1 $15,282 - $23,490	900 Added 3.5%	26,600 $495,000
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $359,788 - $412,698	14,300 Added 125.44%	25,700 $667,000
Q1 2023 May 15, 2023	SELL	$25.91 - $32.1 $15,546 - $19,260	-600 Reduced 5.0%	11,400 $327,000
Q4 2022 Feb 14, 2023	BUY	$23.85 - $31.91 $286,200 - $382,920	12,000 New	12,000 $355,000
Q4 2018 Feb 14, 2019	SELL	$30.16 - $43.0 $953,689 - $1.36 Million	-31,621 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.83 - $42.51 $203,381 - $263,349	-6,195 Reduced 16.38%	31,621 $1.33 Million
Q2 2018 Aug 14, 2018	BUY	$28.77 - $48.27 $771,122 - $1.29 Million	26,803 Added 243.38%	37,816 $1.21 Million
Q1 2018 May 15, 2018	BUY	$49.22 - $68.43 $542,059 - $753,619	11,013 New	11,013 $548,000

125

11.4M

200

100

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $237M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.